Maynard Um
-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Raised to $176 at Wedbush
-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Raised to $185 at Morgan Stanley
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Neurocrine Bio. (NBIX) Following Reports of Soleno Acquisition
-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Lowered to $140 at Truist Securities
-
-
-
-
-
-
-
Data center investments to hit $3 trillion over next five years, says Moody’s
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Neurocrine Bio. (NBIX)
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Neurocrine Bio. (NBIX)
-
396,791 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

